cd8 media Search Results


pool cov-2  (GenOne Media Group)
90
GenOne Media Group pool cov-2
List of peptides chosen in this study, through prediction studies and Spike peptide pool.
Pool Cov 2, supplied by GenOne Media Group, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pool cov-2/product/GenOne Media Group
Average 90 stars, based on 1 article reviews
pool cov-2 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


List of peptides chosen in this study, through prediction studies and Spike peptide pool.

Journal: Cytokine

Article Title: Is IFN expression by NK cells a hallmark of severe COVID-19?

doi: 10.1016/j.cyto.2022.155971

Figure Lengend Snippet: List of peptides chosen in this study, through prediction studies and Spike peptide pool.

Article Snippet: SARS-CoV-2 virus-specific CD4 and CD8 peptides ( ) ( patent number: BR 10 2022 005518 1 ), resuspended in H 2 O (MiliQ), pooled (Pool CoV-2, which contained peptides from the spike protein and non-spike proteins, and Pool Spike Cov-2, which contained peptides from the spike protein only, ) were synthesized (GenOne Biotechnologies, Rio de Janeiro, Brazil) lyophilized and stored at −20 °C until use.

Techniques:

Ki-67 and TIM-3 expression by CD3 - CD56 + NK cells in healthy individuals (HC), mild (mild CoV), and severe (severe CoV) COVID-19 recovered patients.

Journal: Cytokine

Article Title: Is IFN expression by NK cells a hallmark of severe COVID-19?

doi: 10.1016/j.cyto.2022.155971

Figure Lengend Snippet: Ki-67 and TIM-3 expression by CD3 - CD56 + NK cells in healthy individuals (HC), mild (mild CoV), and severe (severe CoV) COVID-19 recovered patients.

Article Snippet: SARS-CoV-2 virus-specific CD4 and CD8 peptides ( ) ( patent number: BR 10 2022 005518 1 ), resuspended in H 2 O (MiliQ), pooled (Pool CoV-2, which contained peptides from the spike protein and non-spike proteins, and Pool Spike Cov-2, which contained peptides from the spike protein only, ) were synthesized (GenOne Biotechnologies, Rio de Janeiro, Brazil) lyophilized and stored at −20 °C until use.

Techniques: Expressing, Control